(Q39175967)

9 September 2017

title

The role and clinical significance of YES-associated protein 1 in human osteosarcoma (English)

1 reference

9 September 2017

Y-H Zhang

1

1 reference

9 September 2017

B Li

2

1 reference

9 September 2017

L Shen

3

1 reference

9 September 2017

Y Shen

4

1 reference

9 September 2017

X-D Chen

5

1 reference

9 September 2017

publication date

1 January 2013

1 reference

International Journal of Immunopathology and Pharmacology

9 September 2017

published in

1 reference

9 September 2017

volume

26

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

157-167

1 reference

Biomarkers in Osteosarcoma

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Yorkie: the final destination of Hippo signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Expression of Yes-associated protein in common solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

YAP is a candidate oncogene for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

An immunohistochemical analysis to evaluate an inverse correlation between Runx2/Cbfa1 and NF kappa B in human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

RUNX2 regulates the effects of TNFalpha on proliferation and apoptosis in SaOs-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600115

10.1177/039463201302600115

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference